{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:41:57Z","timestamp":1761028917251,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12350-021-02630-w","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T14:03:58Z","timestamp":1620396238000},"page":"831-834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Imagine, believe, and achieve"],"prefix":"10.1016","volume":"28","author":[{"given":"Amalia","family":"Peix","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenia","family":"Padr\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-021-02630-w_bib1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/13506129.2015.1072089","article-title":"Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis","volume":"22","author":"Galat","year":"2015","journal-title":"Amyloid"},{"key":"10.1007\/s12350-021-02630-w_bib2","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-021-02630-w_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","article-title":"Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis","volume":"12","author":"Maurer","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1007\/s12350-021-02630-w_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-021-02630-w_bib5","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1007\/s12350-021-02630-w_bib6","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-021-02630-w_bib7","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"10.1007\/s12350-021-02630-w_bib8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1148\/radiol.2015141744","article-title":"Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: A cardiac MR imaging study","volume":"277","author":"Fontana","year":"2015","journal-title":"Radiology"},{"key":"10.1007\/s12350-021-02630-w_bib9","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: A pilot study using (18)F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02630-w_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.114.002954","article-title":"18F-Florbetapir binds specifically to myocardial light chain and transthyretin amyloid deposits: autoradiography study","author":"Park","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-021-02630-w_bib11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12350-019-01643-w","article-title":"Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc- HMDP scintigraphy","volume":"28","author":"Gallini","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-021-02630-w_bib12","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1007\/s12350-019-01893-8","article-title":"Quantitative 99mTc-DPD SPECT\/CT in patients with suspected ATTR cardiac amyloidosis: Feasibility and correlation with visual scores","volume":"27","author":"Caobelli","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-021-02630-w_bib13","article-title":"Absolute quantitation of cardiac 99mTc-pyrophophate using Cadmium Zinc Telluride-based SPECT\/CT","author":"Dorbala","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02630-w_bib14","first-page":"1364","article-title":"Quantitative bone-avid tracer SPECT\/CT for cardiac amyloidosis: A crucial step forward","volume":"13","author":"Dorbala","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-021-02630-w_bib15","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Casta\u00f1o","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-021-02630-w_bib16","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-021-02630-w_bib17","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehv583","article-title":"Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness","volume":"37","author":"Damy","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-021-02630-w_bib18","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.jacc.2018.07.092","article-title":"Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release","volume":"72","author":"Sperry","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-021-02630-w_bib19","doi-asserted-by":"crossref","DOI":"10.1007\/s12350-021-02575-0","article-title":"The prevalence of TTR cardiac amyloidosis among patients undergoing bone scintigraphy","author":"Bianco","year":"2021","journal-title":"J Nucl Cardiol"},{"issue":"S2","key":"10.1007\/s12350-021-02630-w_bib20","first-page":"6","article-title":"Prevalence of transthyretin (ATTR) cardiac amyloidosis in the Australian population estimated using 99mTc-hydroxymethylene diphosphonate planar bone scans","volume":"49","author":"Cuscaden","year":"2019","journal-title":"Int Med J"},{"key":"10.1007\/s12350-021-02630-w_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","article-title":"Native T1 mapping in transthyretin amyloidosis","volume":"7","author":"Fontana","year":"2014","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1007\/s12350-021-02630-w_bib22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","article-title":"Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis","volume":"6","author":"Karamitsos","year":"2013","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1007\/s12350-021-02630-w_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1532-429X-10-54","article-title":"Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis","volume":"10","author":"Maceira","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1007\/s12350-021-02630-w_bib24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jcmg.2017.02.012","article-title":"CMR-verified regression of cardiac AL amyloid after chemotherapy","volume":"11","author":"Martinez-Naharro","year":"2018","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1007\/s12350-021-02630-w_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40336-018-0264-0","article-title":"Advances in clinical molecular imaging instrumentation","volume":"6","author":"Hutton","year":"2018","journal-title":"Clin. Transl. Imaging"},{"key":"10.1007\/s12350-021-02630-w_bib26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1053\/j.semnuclmed.2020.01.001","article-title":"Multimodality imaging in the evaluation and management of cardiac amyloidosis","volume":"50","author":"Khor","year":"2020","journal-title":"Semin Nucl Med"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-021-02630-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-021-02630-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123009315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123009315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-021-02630-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:10:10Z","timestamp":1761027010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123009315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1071358123009315"],"URL":"https:\/\/doi.org\/10.1007\/s12350-021-02630-w","relation":{},"ISSN":["1071-3581"],"issn-type":[{"type":"print","value":"1071-3581"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imagine, believe, and achieve","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-021-02630-w","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}